{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:09:54Z","timestamp":1783523394036,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016040","name":"Takeda Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006126","name":"The Hospital for Sick Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jaip.2023.01.028","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:40:45Z","timestamp":1675219245000},"page":"1725-1733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A\u00a0Real-World Experience"],"prefix":"10.1016","volume":"11","author":[{"given":"Luis","family":"Murguia-Favela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A.M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tehseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Hernandez-Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Seroogy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daime","family":"Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Pettiford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naynesh R.","family":"Kamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Grunebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.01.028_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","article-title":"Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies","volume":"13","author":"Grunebaum","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.028_bib3","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jaci.2012.02.003","article-title":"Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency","volume":"129","author":"Grunebaum","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/srep40136","article-title":"Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients","volume":"7","author":"Sauer","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2023.01.028_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00247-012-2564-2","article-title":"Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life","volume":"43","author":"Manson","year":"2013","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jaip.2023.01.028_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199605233342104","article-title":"Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency","volume":"334","author":"Bollinger","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.028_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.anai.2022.07.016","article-title":"Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency","volume":"129","author":"Hartog","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib9","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.028_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10875-022-01238-0","article-title":"Hematopoietic cell transplantation for adenosine deaminase severe combined immunodeficiency\u2014improved outcomes in the modern era","volume":"42","author":"Ghimenton","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.2022016196","article-title":"Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC","volume":"140","author":"Cuvelier","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.028_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ymthe.2017.12.022","article-title":"Gene therapy for adenosine deaminase deficiency: a comprehensive evaluation of short- and medium-term safety","volume":"26","author":"Cicalese","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaip.2023.01.028_bib13","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex\u00a0vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.028_bib14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0731-7085(96)01845-6","article-title":"Primary structure of bovine adenosine deaminase","volume":"14","author":"Kelly","year":"1996","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jaip.2023.01.028_bib15","first-page":"649","article-title":"Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol","volume":"46","author":"Davis","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.028_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI115761","article-title":"IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency","volume":"89","author":"Chaffee","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.01.028_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","article-title":"First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature","volume":"9","author":"Migliavacca","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108321","article-title":"Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy","volume":"211","author":"Grunebaum","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib22","author":"Chiesi"},{"key":"10.1016\/j.jaip.2023.01.028_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cei.13420","article-title":"Comparison of elapegademase and pegademase in ADA-deficient patients and mice","volume":"200","author":"Murguia-Favela","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib24","first-page":"349","article-title":"Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)","volume":"3","author":"Booth","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.jaip.2023.01.028_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.anai.2020.12.008","article-title":"Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy","volume":"126","author":"Gans","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib26","doi-asserted-by":"crossref","first-page":"32114","DOI":"10.1074\/jbc.M005153200","article-title":"The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities","volume":"275","author":"Blackburn","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2023.01.028_bib27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jaci.2013.11.029","article-title":"Pulmonary alveolar proteinosis in adenosine deaminase-deficient mice","volume":"133","author":"Dhanju","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2018.04.029","article-title":"Neutropenia among patients with adenosine deaminase deficiency","volume":"143","author":"Kim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10875-017-0421-7","article-title":"Long-term outcome of adenosine deaminase-deficient patients\u2014a single-center experience","volume":"37","author":"Scott","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.028_bib30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI116626","article-title":"T\u00a0lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase","volume":"92","author":"Weinberg","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.01.028_bib31","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1182\/blood-2007-05-092429","article-title":"Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients","volume":"111","author":"Cassani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.01.028_bib32","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/eji.200526248","article-title":"Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients","volume":"35","author":"Malacarne","year":"2005","journal-title":"Eur J Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:16Z","timestamp":1761975496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2213219823001149"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A\u00a0Real-World Experience","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}